Home
>
National Drug Code (NDC)
>
Senna
Senna - 62011-0162-1 - (Sennosides)
Drug Information of Senna
| Product NDC: | 62011-0162 |
| Proprietary Name: | Senna |
| Non Proprietary Name: | Sennosides |
| Active Ingredient(s): | 8.6 mg/1 & nbsp; Sennosides |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Senna
| Product NDC: | 62011-0162 |
| Labeler Name: | McKesson |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120518 |
Package Information of Senna
| Package NDC: | 62011-0162-1 |
| Package Description: | 1 BOTTLE in 1 BOX (62011-0162-1) > 100 TABLET in 1 BOTTLE |
NDC Information of Senna
| NDC Code | 62011-0162-1 |
| Proprietary Name | Senna |
| Package Description | 1 BOTTLE in 1 BOX (62011-0162-1) > 100 TABLET in 1 BOTTLE |
| Product NDC | 62011-0162 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Sennosides |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120518 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | McKesson |
| Substance Name | SENNOSIDES A AND B |
| Strength Number | 8.6 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
